Comparing the effectiveness of three different doses of magnesium sulfate added to bupivacaine using spinal anesthesia in patients with below umbilical surgeries

A comparative study of three different doses of magnesium sulphate as adjuvant with injection bupivacaine 0.5 percent heavy for infraumbilical procedures under subarachnoid block - nil

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/05/086920

Enrollment

Registered

2025-05-14

Start date

Unknown

Completion date

Unknown

Last updated

2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: 8- Other Procedures

Interventions

Intervention1: bupivacaine with MgSO4 (50%)(15mg): patients undergoing for infraumbilical surgeries in spinal anesthesia using Inj. Bupivacaine Heavy (0.5%) 3ml plus MgSO4 (50%) 0.1 ml [15mg] plus 0.1

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patients undergoing subarachnoid block for infraumbilical surgeries 2) Patients aged 18 to 60 years 3) Patients of ASA â? , â?¡ and • grade

Exclusion criteria

Exclusion criteria: 1) Patients refusal 2) Uncooperative patients 3) Patients with deformity of spine 4) Patients with coagulation disorder, thrombocytopenia, increased intracranial pressure, severe hypovolemia, severe heart disease, local infection at injection site, allergy to local anaesthetic.

Design outcomes

Primary

Measure	Time frame
To see the duration and efficacy of magnesium sulphate as an adjuvant to bupivacaine heavy in Subarachnoid blockTimepoint: every 10 min for 120min till recovery for 2 months	—

Secondary

Measure	Time frame
compare & evaluate the efficacy of a magnesium sulphate as an adjuvant in three different doses with inj Bupivacaine 0.5% heavy for spinal anaesthesia in terms of block characteristics haemodynamic parameters safety profile & post operative analgesia.Timepoint: every 10 min for 120min till recovery for 2 months	—

Countries

India

Contacts

Public ContactDr Apeksha Sureshbhai Prajapati

pdu college civil hospital rajkot

dr.ashutoshvyas@yahoo.in9898188464

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026